Patents by Inventor Poul Kirketerp Andersson

Poul Kirketerp Andersson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5853718
    Abstract: A vertebrate animal, such as a human, is immunized with a bacterial host cell harboring a recombinant replicon which provides a stochastically expressed cell killing function whereby the cells are biologically contained. The replicon also comprises a gene encoding an antigen which is to be displayed on the outer surface of the host cell, so that it can elicit an immune response from the immunized animal. This antigen comprises one or more epitopes from a pathogenic agent.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: December 29, 1998
    Assignee: Genexpress ApS
    Inventors: S.o slashed.ren Molin, Poul Kirketerp Andersson, Kenn Ax.o slashed. Gerdes, Per Klemm
  • Patent number: 5702916
    Abstract: A replicon, in which a nucleotide sequence encoding a cell killing function is regulatably expressed when the replicon is harbored in one type of host cell (primary host cell), so that cells harboring the replicon are killed under conditions under which the cell killing function is expressed, and the nucleotide sequence encoding the cell killing function is regulatably or constitutively expressed when the replicon is harbored in another type of host cell (secondary host cell), so that cells harboring the replicon are invariably killed or killed under conditions under which the cell killing function is expressed, may be used in a method of active biological containment of cells under defined environmental conditions. The biological containment principle may be utilized in the industrial production of a biosynthetic product by recombinant DNA techniques, when deliberately releasing a genetically engineered microorganism to the natural environment or in the preparation of a live vaccine.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: December 30, 1997
    Assignee: GX Biosystems A/S
    Inventors: S.o slashed.ren Molin, Poul Kirketerp Andersson, Kenn Axo Gerdes, Per Klemm
  • Patent number: 5670370
    Abstract: A replicon, in which a nucleotide sequence encoding a cell killing function is regulatably expressed when the replicon is harboured in one type of host cell (primary host cell), so that cells harbouring the replicon are killed under conditions under which the cell killing function is expressed, and the nucleotide sequence encoding the cell killing function is regulatably or constitutively expressed when the replicon is harboured in another type of host cell (secondary host cell), so that cells harbouring the replicon are invariably killed or killed under conditions under which the cell killing function is expressed, may be used in a method of active biological containment of cells under defined environmental conditions.The biological containment principle may be utilized in the industrial production of a biosynthetic product by recombinant DNA techniques, when deliberately releasing a genetically engineered microorganism to the natural environment or in the preparation of a live vaccine.
    Type: Grant
    Filed: May 30, 1995
    Date of Patent: September 23, 1997
    Assignee: GX BioSystems A/S
    Inventors: S.o slashed.ren Molin, Poul Kirketerp Andersson, Kenn Ax.o slashed. Gerdes, Per Klemm